These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 29769286)
1. Targeted inhibition of histone H3K27 demethylation is effective in high-risk neuroblastoma. Lochmann TL; Powell KM; Ham J; Floros KV; Heisey DAR; Kurupi RIJ; Calbert ML; Ghotra MS; Greninger P; Dozmorov M; Gowda M; Souers AJ; Reynolds CP; Benes CH; Faber AC Sci Transl Med; 2018 May; 10(441):. PubMed ID: 29769286 [TBL] [Abstract][Full Text] [Related]
2. Histone demethylase UTX is a therapeutic target for diabetic kidney disease. Chen H; Huang Y; Zhu X; Liu C; Yuan Y; Su H; Zhang C; Liu C; Xiong M; Qu Y; Yun P; Zheng L; Huang K J Physiol; 2019 Mar; 597(6):1643-1660. PubMed ID: 30516825 [TBL] [Abstract][Full Text] [Related]
3. EZH2, JMJD3, and UTX epigenetically regulate hepatic plasticity inducing retro-differentiation and proliferation of liver cells. Pediconi N; Salerno D; Lupacchini L; Angrisani A; Peruzzi G; De Smaele E; Levrero M; Belloni L Cell Death Dis; 2019 Jul; 10(7):518. PubMed ID: 31285428 [TBL] [Abstract][Full Text] [Related]
4. Therapeutic potential of GSK-J4, a histone demethylase KDM6B/JMJD3 inhibitor, for acute myeloid leukemia. Li Y; Zhang M; Sheng M; Zhang P; Chen Z; Xing W; Bai J; Cheng T; Yang FC; Zhou Y J Cancer Res Clin Oncol; 2018 Jun; 144(6):1065-1077. PubMed ID: 29594337 [TBL] [Abstract][Full Text] [Related]
5. GSK-J4: An H3K27 histone demethylase inhibitor, as a potential anti-cancer agent. Dalpatraj N; Naik A; Thakur N Int J Cancer; 2023 Sep; 153(6):1130-1138. PubMed ID: 37165737 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of H3K27me3 Demethylases Promotes Plasmablast Formation. Kania AK; Guo M; Scharer CD; Boss JM Immunohorizons; 2021 Dec; 5(12):918-930. PubMed ID: 34880105 [TBL] [Abstract][Full Text] [Related]
7. Elevating H3K27me3 level sensitizes colorectal cancer to oxaliplatin. Wang Q; Chen X; Jiang Y; Liu S; Liu H; Sun X; Zhang H; Liu Z; Tao Y; Li C; Hu Y; Liu D; Ye D; Liu Y; Wang M; Zhang X J Mol Cell Biol; 2020 Feb; 12(2):125-137. PubMed ID: 31065671 [TBL] [Abstract][Full Text] [Related]
8. Effects of GSK-J4 on JMJD3 Histone Demethylase in Mouse Prostate Cancer Xenografts. Sanchez A; Penault-Llorca F; Bignon YJ; Guy L; Bernard-Gallon D Cancer Genomics Proteomics; 2022; 19(3):339-349. PubMed ID: 35430567 [TBL] [Abstract][Full Text] [Related]
9. Low HOX gene expression in PML-RARα-positive leukemia results from suppressed histone demethylation. Rejlova K; Musilova A; Kramarzova KS; Zaliova M; Fiser K; Alberich-Jorda M; Trka J; Starkova J Epigenetics; 2018; 13(1):73-84. PubMed ID: 29224413 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of demethylase KDM6B sensitizes diffuse large B-cell lymphoma to chemotherapeutic drugs. Mathur R; Sehgal L; Havranek O; Köhrer S; Khashab T; Jain N; Burger JA; Neelapu SS; Davis RE; Samaniego F Haematologica; 2017 Feb; 102(2):373-380. PubMed ID: 27742770 [TBL] [Abstract][Full Text] [Related]
11. The antischistosomal potential of GSK-J4, an H3K27 demethylase inhibitor: insights from molecular modeling, transcriptomics and in vitro assays. Lobo-Silva J; Cabral FJ; Amaral MS; Miyasato PA; de Freitas RP; Pereira ASA; Khouri MI; Barbosa MMF; Ramos PIP; Leite LCC; Asojo OA; Nakano E; Verjovski-Almeida S; Farias LP Parasit Vectors; 2020 Mar; 13(1):140. PubMed ID: 32178714 [TBL] [Abstract][Full Text] [Related]
12. The histone demethylase inhibitor GSK-J4 limits inflammation through the induction of a tolerogenic phenotype on DCs. Doñas C; Carrasco M; Fritz M; Prado C; Tejón G; Osorio-Barrios F; Manríquez V; Reyes P; Pacheco R; Bono MR; Loyola A; Rosemblatt M J Autoimmun; 2016 Dec; 75():105-117. PubMed ID: 27528513 [TBL] [Abstract][Full Text] [Related]
13. Venetoclax-based Rational Combinations are Effective in Models of Dalton KM; Krytska K; Lochmann TL; Sano R; Casey C; D'Aulerio A; Khan QA; Crowther GS; Coon C; Cai J; Jacob S; Kurupi R; Hu B; Dozmorov M; Greninger P; Souers AJ; Benes CH; Mossé YP; Faber AC Mol Cancer Ther; 2021 Aug; 20(8):1400-1411. PubMed ID: 34088831 [TBL] [Abstract][Full Text] [Related]
14. Oncogenic KRAS Sensitizes Lung Adenocarcinoma to GSK-J4-Induced Metabolic and Oxidative Stress. Hong BJ; Park WY; Kim HR; Moon JW; Lee HY; Park JH; Kim SK; Oh Y; Roe JS; Kim MY Cancer Res; 2019 Nov; 79(22):5849-5859. PubMed ID: 31506334 [TBL] [Abstract][Full Text] [Related]
15. The histone H3 lysine-27 demethylase Jmjd3 plays a critical role in specific regulation of Th17 cell differentiation. Liu Z; Cao W; Xu L; Chen X; Zhan Y; Yang Q; Liu S; Chen P; Jiang Y; Sun X; Tao Y; Hu Y; Li C; Wang Q; Wang Y; Chen CD; Shi Y; Zhang X J Mol Cell Biol; 2015 Dec; 7(6):505-16. PubMed ID: 25840993 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic potential of inhibiting histone 3 lysine 27 demethylases: a review of the literature. Abu-Hanna J; Patel JA; Anastasakis E; Cohen R; Clapp LH; Loizidou M; Eddama MMR Clin Epigenetics; 2022 Aug; 14(1):98. PubMed ID: 35915507 [TBL] [Abstract][Full Text] [Related]
17. Antiproliferative effect of the histone demethylase inhibitor GSK-J4 in chondrosarcomas. Lhuissier E; Aury-Landas J; Allas L; Boittin M; Boumediene K; Baugé C IUBMB Life; 2019 Nov; 71(11):1711-1719. PubMed ID: 31241814 [TBL] [Abstract][Full Text] [Related]
18. H3K27me3 demethylases regulate in vitro chondrogenesis and chondrocyte activity in osteoarthritis. Yapp C; Carr AJ; Price A; Oppermann U; Snelling SJ Arthritis Res Ther; 2016 Jul; 18(1):158. PubMed ID: 27388528 [TBL] [Abstract][Full Text] [Related]
19. Identification of JmjC domain-containing UTX and JMJD3 as histone H3 lysine 27 demethylases. Hong S; Cho YW; Yu LR; Yu H; Veenstra TD; Ge K Proc Natl Acad Sci U S A; 2007 Nov; 104(47):18439-44. PubMed ID: 18003914 [TBL] [Abstract][Full Text] [Related]
20. Histone H3K27me3 demethylases regulate human Th17 cell development and effector functions by impacting on metabolism. Cribbs AP; Terlecki-Zaniewicz S; Philpott M; Baardman J; Ahern D; Lindow M; Obad S; Oerum H; Sampey B; Mander PK; Penn H; Wordsworth P; Bowness P; de Winther M; Prinjha RK; Feldmann M; Oppermann U Proc Natl Acad Sci U S A; 2020 Mar; 117(11):6056-6066. PubMed ID: 32123118 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]